← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

15,000

Price

$0

Filed

Jun 11

Insider

Name

Malabre Richard C

Title

SVP, Chief Accounting Officer

CIK

0002007730

Roles

Officer

Transaction Details

Transaction Date

2025-06-09

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

321,000

Footnotes

This stock option exercise was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024. | This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024. | The shares were sold at prices ranging from $4.00 to $4.03 and the price reported reflects the weighted average sale price. | The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Filing Info

Accession No.

0001562180-25-004717

Form Type

4

Issuer CIK

0001517022

Malabre Richard C's History

Date Ticker Type Value
2025-06-09 AKBA M $25K
2025-06-09 AKBA $60K
2025-06-09 AKBA M $0
2025-06-04 AKBA $47K

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Vickers Philip J. 2026-04-01